Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder
A National Institute of Mental Health study is conducting a prospective natural history study of motor activity and mood states in bipolar d…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder [Phase 4]
Phase 4 clinical trial evaluating an individualized pharmacological approach to obesity in patients with bipolar disorder (bipolar I and II)…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Time and Virtual Reality in Schizophrenia and Bipolar Disorder [NA]
A clinical trial evaluating time and virtual reality interventions for schizophrenia and bipolar disorder is currently recruiting.
-
EMA other · 2026-03-10EMA Opinion under re-examination: Iloperidone Vanda Pharmaceuticals (iloperidone) — Vanda Pharmaceuticals Netherlands B.V.
EMA has issued an opinion under re-examination for iloperidone by Vanda Pharmaceuticals Netherlands B.V. for schizophrenia and bipolar disor…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: LHC-CIDI-5 in Hong Kong
A clinical trial update indicates that LHC-CIDI-5 is currently recruiting in Hong Kong for multiple psychiatric conditions, including major …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
A recruiting clinical trial evaluating biomarkers and biotypes, disease course in early psychosis, and specialty services for schizophrenia-…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Signature Response to Light Therapy in Unipolar and Bipolar Major Depressive Episode (MDE) [NA]
A clinical trial is evaluating light therapy for unipolar and bipolar major depressive episodes, sponsored by Assistance Publique - Hôpitaux…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Time Restricted Eating (TRE) in Bipolar Disorder [NA]
Update on a clinical trial studying time-restricted eating in bipolar disorder; the study is not yet recruiting.
-
FDA approval · 2026-03-06FDA Approved: CARBAMAZEPINE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for carbamazepine from Apotex Corp., granting approval for the generic product under ANDA075948. The…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Contribution of Virtual Reality Eye Tracking in the Identification of Schizophrenia, Bipolar and Depression [NA]
This ongoing clinical trial explores whether virtual reality eye tracking can help identify schizophrenia, bipolar disorder, and major depre…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections: Translating Epidemiology to Deep-phenotyping.
This ClinicalTrials.gov update describes a study examining how prior viral infections influence susceptibility and resilience to mental illn…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Ketamine for Treatment-Resistant Bipolar Disorder [Phase 2]
A Phase 2 clinical trial evaluating ketamine for treatment-resistant bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression [Phase 2]
A Phase 2 completed trial update evaluating maintenance ketamine infusions for treatment-resistant bipolar depression.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Novel Blood Test as a Biomarker in Mental Health
This clinical trial investigates a novel blood test biomarker for mental health conditions. The study (NCT06856161) is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Adjunctive Bright Light Therapy in Patients With Bipolar Depression and Eveningness [NA]
A clinical trial update for adjunctive bright light therapy in adults with bipolar depression who have an eveningness chronotype.
-
FDA approval · 2026-03-05FDA Approved: OLANZAPINE — Original Application (GLENMARK PHARMACEUTICALS INC., USA)
FDA approved Glenmark's original application for a generic olanzapine product.
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical Applications [NA]
A clinical trial exploring brain network mechanisms underlying cognitive impairments across schizophrenia, bipolar disorder, and major depre…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Neuromodulation for Enhancement of Emotion Regulation in Bipolar Mood Disorders [NA]
A completed clinical trial update from Massachusetts General Hospital on using neuromodulation to enhance emotion regulation in bipolar diso…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Technology-Assisted Implementation of a Mobile Health Program for Serious Mental Illness [NA]
This entry reports a completed clinical trial from the University of Washington evaluating technology-assisted implementation of a mobile he…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Neurostimulation Versus Therapy for Problems With Emotions [NA]
A Duke University-sponsored trial is comparing neurostimulation to therapy for problems with emotion regulation across mood and anxiety diso…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Pilot Study of Neuromodulation for Enhancement of Emotion Regulation in Bipolar Mood Disorders [NA]
A completed pilot trial investigated transcranial magnetic stimulation as a neuromodulation approach to enhance emotion regulation in bipola…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Medication Adherence in Severe Mental Illness: a Promotion Program [NA]
This document announces a clinical trial focused on promoting medication adherence in severe mental illness, including bipolar disorder and …
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: University of Iowa Interventional Psychiatry Service Patient Registry
This clinical trial registry entry from the University of Iowa Interventional Psychiatry Service is recruiting participants for a patient re…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: PROgram To Enhance Cardiovascular Risk Trough an Intervention of Nutrition in Bipolar Disorder [NA]
It describes an ongoing University of Sao Paulo-sponsored clinical trial evaluating a nutrition-based intervention to lower cardiovascular r…
-
EMA approval · 2026-02-27EMA Authorised: Zyprexa (olanzapine) — CHEPLAPHARM Registration GmbH
The EMA authorised Zyprexa (olanzapine) for schizophrenia and bipolar disorder under CHEPLAPHARM Registration GmbH as the marketing authoris…